• Nenhum resultado encontrado

Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

N/A
N/A
Protected

Academic year: 2017

Share "Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors."

Copied!
13
0
0

Texto

Loading

Imagem

Fig 1. Inclusion, screening, and group assignment of patients. Among 1310 non-small-cell lung cancer patients diagnosed between January 2011 and October 2013, 253 patients were included into final analysis.
Table 1. Clinical characteristics and therapy responses of all 253 patients.
Fig 2. Progression-free survival (PFS) of epidermal growth factor receptor mutant non-small-cell lung cancer patients treated with first-line tyrosine kinase inhibitors therapy
Table 2. Survival analysis of lymphocyte-to-monocyte ratio and clinical factors.
+4

Referências

Documentos relacionados

American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung

The model validation was performed comparing the results of modal numerical analysis with the in situ measurements, for which a set of dynamic tests was carried out in order

Nesse am- biente, o zinco é também fixado pelos fosfatos (Vino- graclov 1959). A mobilidade do zinco não é função apenas do p11. Do mesmo modo que para os outros elementos me- nores,

To analyze and describe a series of patients with non- small cell lung cancer treated with erlotinib during a period prior to the mandatory investigation of the epidermal

The aim of this study was to evaluate the frequency of epidermal growth factor receptor and KRAS mutations in a population of Brazilian patients with non-small cell lung

Do conjunto de críticos vindos das gerações anteriores, Fernando Pernes, ainda que nunca se debruçando em concreto sobre o trabalho de Sarmento destes anos nos textos

Objective regression in non-small cell lung cancer patients treated in phase I trials of oral ZD 1839 (Iressa), a selective tyrosine kinase inhibitor that blocks the epidermal

Neste sentido foi proposto um modelo que permitisse explicitar esta relação, bem como identificar e explicar a forma como a qualidade de vida e a comunicação da marca